Interní Med. 2012; 14(12): 455-457

The treatment of chronic rhinosinusitis

MUDr.Jiří Hoza
Otolaryngologická klinika, Fakultní nemocnice Olomouc

The treatment of chronic rhinosinusitis (CRS) represents a major problem given the prevalence of this condition in the population

and the resulting socioeconomic impacts. The etiology and pathogenesis of CRS are discussed. The treatment involves both conservative

and surgical methods. In addition to the standardly used topical steroids, conservative therapy mainly employs so-called

immunolides (e.g. erdosteine), systemic pharmaceuticals that block the mediators involved in the complex chain of CRS development.

Surgical treatment, with the exception of complications, is regarded as second-choice modality, with modern technological

procedures being used, such as FESS (functional endoscopic sinus surgery), a microsurgical mini-invasive method with minimal

morbidity for the patient.

erdosteine.

Keywords: chronic rhinosinusitis (CRS), paranasal sinuses, ostiomeatal unit, functional endoscopic sinus surgery (FESS), corticosteroids,

Published: January 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hoza J. The treatment of chronic rhinosinusitis. Interní Med. 2012;14(12):455-457.
Download citation

References

  1. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol. Head Neck Surg 2003; 129(3 Suppl): S1-S32. Go to original source... Go to PubMed...
  2. Jan Rottenberg, Klinika otorinolaryngologie a chirurgie hlavy a krku, FN u sv. Anny v Brně, Klin Farmakol Farm 2006; 20: 83-86.
  3. Georgitis JW, Matthews BL, Stone B.Chronic sinusitid: charakterization of cellular influx and inflammatory mediators in sinus Lavre fluid. Int Arch Allergy Immunol. 1995; 106: 416-421. Go to original source... Go to PubMed...
  4. Sičák, a kol. Rinológia, choroby nosa a prínosových dutin, 2006.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.